A Dose-response Evaluation of ALK (the Sponsor) Tree Allergy Immunotherapy Tablet

Clinical trial NCT01675791 · COMPLETED

Trial details

NCT number: NCT01675791
Sponsor: ALK-Abelló A/S
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Birch Pollen Allergy

Start date: 2012-08-01
Primary completion: 2013-07-01
Enrollment: 637

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.